blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2662078

EP2662078 - Methods to Treat Allergic Conditions [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.12.2020
Database last updated on 15.06.2024
FormerExamination is in progress
Status updated on  23.08.2017
Most recent event   Tooltip11.12.2020Application deemed to be withdrawnpublished on 13.01.2021  [2021/02]
Applicant(s)For all designated states
National Jewish Health
1400 Jackson Street
Denver, CO 80206 / US
[2013/46]
Inventor(s)01 / Gelfand, Erwin W.
4275 South Bellaire Circle
Engelwood CO 80113 / US
02 / Wang, Meiquin
1015 South Birch Street a312
Gelndale CO 80246 / US
 [2013/46]
Representative(s)Evens, Paul Jonathan
Maguire Boss
24 East Street
St. Ives, Cambridgeshire PE27 5PD / GB
[N/P]
Former [2013/46]Evens, Paul Jonathan
Maguire Boss 24 East Street St. Ives
Cambridgeshire PE27 5PD / GB
Application number, filing date13177100.810.11.2011
[2013/46]
Priority number, dateUS20100412194P10.11.2010         Original published format: US 412194 P
[2013/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2662078
Date:13.11.2013
Language:EN
[2013/46]
Search report(s)(Supplementary) European search report - dispatched on:EP15.10.2013
ClassificationIPC:A61K31/00, A61P37/08, A61K31/553
[2013/46]
CPC:
A61K38/1719 (EP,US); A61K31/00 (EP,US); A61K31/4045 (EP,US);
A61K31/553 (EP,US); A61K31/7052 (EP,US); A61P1/00 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P17/00 (EP); A61P29/00 (EP);
A61P37/08 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/46]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Verfahren zur Behandlung von allergischen Zuständen[2013/46]
English:Methods to Treat Allergic Conditions[2013/46]
French:Procédés pour traiter des états allergiques[2013/46]
Examination procedure12.05.2014Amendment by applicant (claims and/or description)
12.05.2014Examination requested  [2014/26]
22.03.2016Despatch of a communication from the examining division (Time limit: M06)
23.09.2016Reply to a communication from the examining division
14.08.2017Despatch of a communication from the examining division (Time limit: M04)
04.12.2017Reply to a communication from the examining division
05.11.2018Despatch of a communication from the examining division (Time limit: M04)
26.02.2019Reply to a communication from the examining division
07.04.2020Despatch of a communication from the examining division (Time limit: M04)
18.08.2020Application deemed to be withdrawn, date of legal effect  [2021/02]
09.09.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/02]
Parent application(s)   TooltipEP11805677.9  / EP2637650
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.03.2016
Fees paidRenewal fee
18.11.2013Renewal fee patent year 03
10.11.2014Renewal fee patent year 04
10.11.2015Renewal fee patent year 05
10.11.2016Renewal fee patent year 06
13.11.2017Renewal fee patent year 07
14.11.2018Renewal fee patent year 08
14.11.2019Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XYI]WO2004058042  (YEDA RES & DEV [IL], et al) [X] 1-4,15 * page 6, line 20 - page 7, line 1 * * examples 3,4 * [Y] 1-16 [I] 1-16;
 [X]WO2004058749  (VERTEX PHARMA [US], et al) [X] 1,3,4,6-9,11,15 * paragraphs [0133] , [0151] *;
 [X]US2004142864  (BREMER RYAN [US], et al) [X] 1,3,4,6-9,11,15 * paragraphs [0178] , [0185] , [0186] *;
 [X]WO0062781  (LANG FLORIAN [DE], et al) [X] 1,3,6-9,11,12,15 * claims 5,6 *;
 [X]WO2006002422  (CHIRON CORP [US], et al) [X] 1,3,4,6-9,11,12,15 * paragraphs [0051] , [0303] , [0306] , [0307] , [0428] *;
 [Y]  - CAO YONGHAO ET AL, "Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression", EUROPEAN JOURNAL OF IMMUNOLOGY, (20100902), vol. 40, no. 11, ISSN 0014-2980, pages 3198 - 3209, XP009173065 [Y] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1002/eji.201040570
 [X]  - SHIN Y ET AL, "The Effects of a Pim Kinase Inhibitor on Allergen-Induced Airway Hyperresponsiveness (AHR) and Inflammation", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY, INC, US, vol. 125, no. 2, doi:10.1016/J.JACI.2009.12.968, ISSN 0091-6749, (20100201), page AB63, (20100201), XP026901649 [X] 1,3-9,11,15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jaci.2009.12.968
 [A]  - T.G. Davis, L. Jackson, S. Marusic, J. Robinson, L. Carter, A.D. Wright, "Small molecule dual antagonists of Pim 1 and 3 kinases ameliorate experimental autoimmune encephalomyelitis", (20101014), 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)&15th Annual Conference of Rehabilitation in MS (RIMS)13.10.2010 - 16.10.2010, URL: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=113502&XNSPRACHE_ID=2&XNKONGRESS_ID=126&XNMASKEN_ID=900, (20120209), XP002669091 [A] 1-16 * the whole document *
 [XP]  - WANG M ET AL, "Inhibition of Pim1/3 Kinase Prevents Peanut-Induced Diarrhea and Intestinal Inflammation by Enhancing Runx3 Expression and Suppressing Th2 and Th17 Cell Differentiation", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY, INC, US, (20110201), vol. 127, no. 2, Suppl, ISSN 0091-6749, page AB234, XP009156299 [XP] 1,3-9,11,12,15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jaci.2010.12.932
by applicantUS2011014485
 US2011144100
    - AMARAVADI, R. ET AL., J. CLIN INVEST, (2005), vol. 115, pages 2618 - 2624
    - CHENG, J.Q. ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 9267 - 9271
    - BELLACOSA, A. D. ET AL., INT J. CANCER, (1995), vol. 64, pages 280 - 285
    - STAHL., J.M. ET AL., CANCER RES., (2004), vol. 64, pages 7002 - 7010
    - MASURE, S.B. ET AL., EUR. J. BIOCHEM., (1999), vol. 265, pages 353 - 360
    - YANG, L. ET AL., CANCER RES., (2004), vol. 64, pages 4394 - 4399
    - KONDAPAKA, S.B. ET AL., MOL. CANCER THER., (2003), vol. 2, pages 1093 - 1103
    - VAN LOHUIZEN, M. ET AL., CELL, (1989), vol. 56, pages 673 - 682
    - BACHMANN, M. ET AL., INT. J. BIOCHEM. CELL BIOL., (2005), vol. 37, pages 726 - 730
    - WANG, Z. ET AL., J. VET. SCI., (2001), vol. 2, pages 167 - 179
    - AMARAVADI R. ET AL., J. CLIN INVEST., (2005), vol. 115, pages 2618 - 2624
    - MIKKERS, H. ET AL., MOL CELL BIOL, (2004), vol. 24, pages 6104 - 6115
    - FOX, C.J. ET AL., J. EXP. MED., (2005), vol. 201, pages 259 - 266
    - AMSON, R. ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 8857 - 8861
    - VALDMAN, A. ET AL., PROSTRATE, (2004), vol. 60, pages 367 - 371
    - CIBULL, T.L. ET AL., J. CLIN. PATHOL., (2006), vol. 59, pages 285 - 288
    - NIEBOROWSKA-SKORSKA, M. ET AL., BLOOD, (2002), vol. 99, pages 4531 - 4539
    - TEMPLE, R. ET AL., AM. J. RESPIR. CELL MOL. BIOL., (2001), vol. 25, pages 425 - 433
    - ANDINA, N. ET AL., J. ALLERGY CLIN. IMMUNOL., (2009), vol. 123, pages 603 - 611
    - STOUT, B.A. ET AL., J. IMMUNOL, (2004), vol. 173, pages 6409 - 6417
    - FOX, C.J. ET AL., J. EXP MED., (2005), vol. 201, pages 259 - 266
    - WANG Z ET AL., J VET SCI., (2001), vol. 2, no. 3, pages 167 - 179
    - AHO TL ET AL., BMC CELL BIOL., (2006), vol. 7, pages 21 - 29
    - RAINIO EM ET AL., J IMMUNOL., (2002), vol. 168, no. 4, pages 1524 - 7
    - WINGETT D ET AL., J IMMUNOL., (1996), vol. 156, no. 2, pages 549 - 57
    - RAINIO EM ET AL., J IMMUNOL., (2002), vol. 168, no. 4, pages L524 - 7
    - YAN, B. ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 45358 - 45367
    - CHEN, X.P. ET AL., PROC. NATL. ACAD. SCI. USA, (2002), vol. 99, pages 2175 - 2180
    - MAITA, H. ET AL., EUR. J. BIOCHEM., (2000), vol. 267, pages 5168 - 5178
    - KOIKE, N. ET AL., FEBS LETT, (2000), vol. 467, pages 17 - 21
    - WANG, Z. ET AL., ARCH BIOCHEM BIOPHYS, (2001), vol. 390, pages 9 - 18
    - RAINIO, E.M. ET AL., J. IMMUNOL, (2002), vol. 168, pages 1524 - 1527
    - PATRA, A.K., J. IMMUNOL., (2006), vol. 177, pages 4567 - 4576
    - BUSS, W.W. ET AL., AM J RESPIR CRIT CARE MED., (1995), vol. 152, pages 388 - 393
    - ROBINSON, D.S. ET AL., N. ENGL J. MED., (1992), vol. 326, pages 298 - 304
    - COHN, L. ET AL., J. EXP. MED., (1997), vol. 186, pages 1731 - 1747
    - HOGAN, S.P. ET AL., J. IMMUNOL., (1998), vol. 161, pages 1501 - 1509
    - AZZAWI, M. ET AL., AM. REV. RESPIR. DIS., (1990), vol. 142, pages 1407 - 1413
    - HAMELMANN, E. ET AL., J. EXP MED., (1996), vol. 183, pages 1719 - 1729
    - ISOGAI, S. ET AL., J. ALLERGY. CLIN. IMMUNOL., (2004), vol. 114, pages 1345 - 1352
    - MIYAHARA, N. ET AL., J. LMMUNOL., (2004), vol. 172, pages 2549 - 2558
    - MIYAHARA, N. ET AL., NAT. MED., (2004), vol. 10, pages 865 - 869
    - CROFT, M. ET AL., J. EXP MED., (1994), vol. 180, pages 1715 - 1728
    - SEDER, R.A. ET AL., J. IMMUNOL., (1992), vol. 148, pages 1652 - 1656
    - COYLE, A. J. ET AL., J. EXP. MED., (1995), vol. 181, pages 1229 - 1233
    - BUSS, W.W. ET AL., N. ENGL. J. MED., (2001), vol. 344, pages 350 - 362
    - UMETSU, D. T. ET AL., NAT. IMMUNOL., (2002), vol. 3, pages 715 - 720
    - WILLS-KARP, M. ET AL., SCIENCE, (1998), vol. 282, pages 2258 - 2261
    - ROBINSON, D.S. ET AL., N. ENGL. J. MED., (1992), vol. 326, pages 298 - 304
    - AARONSON, D.S. ET AL., SCIENCE, (2002), vol. 296, pages 1653 - 1655
    - FAINARU, O. ET AL., EMBO J., (2004), vol. 23, pages 969 - 979
    - FAINARU, 0. ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 10598 - 10603
    - OKUDA, T. ET AL., CELL, (1996), vol. 84, pages 321 - 330
    - DUCY, P. ET AL., CELL, (1997), vol. 89, pages 747 - 745
    - LEVANON, D. ET AL., GENOMICS, (1994), vol. 23, pages 425 - 432
    - HAAGERUP, A. ET AL., ALLERGY, (2002), vol. 57, pages 680 - 686
    - CALABI, F. ET AL., GENOMICS, (1995), vol. 26, pages 607 - 610
    - BRENNER 0 ET AL., PROC NATL ACAD SCI USA., (2004), vol. 101, no. 45, pages 16016 - 21
    - FAINARU O ET AL., EMBO J., (2004), vol. 23, no. 4, pages 969 - 79
    - KOMINE O ET AL., J EXP MED., (2003), vol. 198, no. 1, pages 51 - 61
    - KWEON MN ET AL., J CLIN INVEST, (2000), vol. 106, pages 199 - 206
    - WANG M ET AL., J. ALLERGY CLIN IMMUNOL, (2010), vol. 126, no. 2, pages 306 - 316
    - KNIGHT AK ET AL., AM J PHYSIOL GASTROINTEST LIVER PHYSIOL., (2007), vol. 293, no. 6, pages 1234 - 43
    - KWEON MN ET AL., J CLIN INVEST., (2000), vol. 106, no. 2, pages 199 - 206
    - EIGENMANN PA., PEDIATR ALLERGY IMMUNOL, (2002), vol. 13, pages 162 - 71
    - EIGENMANN PA ET AL., ADV EXP MED BIOL, (1996), vol. 409, page 217
    - BLUMCHEN K ET AL., J ALLERGY CLIN IMMUNOL., (2010), vol. 126, no. 1, pages 83 - 91
    - TESMER LA ET AL., IMMUNOL REV., (2008), vol. 223, pages 87 - 113
    - KOLLS JK; LINDEN A., IMMUNITY, (2004), vol. 21, pages 467 - 476
    - IVANOV II ET AL., CELL, (2006), vol. 126, no. 6, pages 1121 - 33
    - WANG, M. ET AL., J. ALLERGY CLIN. IMMUNOL., (2010), vol. 126, pages 306 - 316
    - LI, X.M. ET AL., J. ALLERGY CLIN. IMMUNOL., (2000), vol. 106, pages 150 - 158
    - WANG, M., J. ALLERGY CLIN. IMMUNOL., (2010), vol. 126, pages 306 - 316
    - KOMINE, O. ET AL., J. EXP. MED., (2003), vol. 198, pages 51 - 61
    - ASHINO, S. ET AL., INTL IMMUNOL., (2010), vol. 22, pages 503 - 513
    - OHNISHI, H. ET AL., J. ALLERGY CLIN IMMUNOL., (2008), vol. 121, pages 864 - 871
    - AHO, T.L. ET AL., BMC CELL BIOL., (2006), vol. 7, pages 21 - 29
    - TESMER, L.A. ET AL., IMMUNOL. REV, (2008), vol. 223, pages 87 - 113
    - KOLLS J.K. ET AL., IMMUNITY, (2004), vol. 21, pages 467 - 476
    - LAJOIE, S. ET AL., NAT IMMUNOL., (2010), vol. 11, pages 928 - 935
    - COLLINS, A. ET AL., NAT. REV. IMMUNOL., (2009), vol. 9, pages 106 - 115
    - TAKEDA, K. ET AL., EUR. RESPIR. J., (2005), vol. 26, pages 577 - 585
    - LOPEZ-RAMOS, M. ET AL., FASEB J., (2010), vol. 24, pages 3171 - 3185
    - YAN BIN ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 45358 - 45367
    - FOX, C. J. ET AL., GENES DEV., (2003), vol. 17, pages 1841 - 1854
    - TAKEDA, K., J. EXP. MED., (1997), vol. 186, pages 449 - 454
    - TOMKINSON, A. ET AL., AM J. RESPIR. CRIT. CARE MED., (2001), vol. 163, pages 721 - 730
    - OSHIBA, A. ET AL., J. CLIN INVEST., (1996), vol. 97, pages 1398 - 1408
    - MIYAHARA, N. ET AL., J. IMMUNOL., (2004), vol. 172, pages 2549 - 2558
    - GAVETT, S. H.; X. CHEN; F. FINKELMAN; M. WILLS-KARP, "Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia", AM J RESPIR CELL MOL BIOL, (1994), vol. 10, pages 587 - 593, XP009034204
    - UMETSU, D. T.; J. J. MCLNTIRE; O. AKBARI; C. MACAUBAS; R. H. DEKRUYFF, "Asthma: an epidemic of dysregulated immunity", NAT IMMINOL, (2002), vol. 3, doi:doi:10.1038/ni0802-715, pages 715 - 720, XP002502439

DOI:   http://dx.doi.org/10.1038/ni0802-715
    - HOGAN, S. P.; K. I. MATTHAEI; J. M. YOUNG; A. KOSKINEN; 1. G. YOUNG; P. S. FOSTER, "A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5", J IMMUNOL, (1998), vol. 161, pages 1501 - 1509
    - WILLS-KARP, M.; J. LUYIMBAZI; X. XU; B. SCHOFIELD; T. Y. NEBEN; C. L. KARP; D. D. DONALDSON, "Interleukin-13: central mediator of allergic asthma", SCIENCE, (1998), vol. 282, doi:doi:10.1126/science.282.5397.2258, pages 2258 - 2261, XP002966772

DOI:   http://dx.doi.org/10.1126/science.282.5397.2258
    - ROBINSON, D. S.; Q. HAMID; S. YING; A. TSICOPOULOS; J. BARKANS; A. M. BENTLEY; C. CORRIGAN; S. R. DURHAM; A. B. KAY, "Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma", N ENGL J MED, (1992), vol. 326, pages 298 - 304
    - AARONSON, D. S.; C. M. HORVATH, "A road map for those who don't know JAK-STAT", SCIENCE, (2002), vol. 296, pages 1653 - 1655, XP055476912
    - BACHMANN, M.; T. MOROY, "The serine/threonine kinase Pim-1", INT J BIOCHEM CELL BIOL, (2005), vol. 37, doi:doi:10.1016/j.biocel.2004.11.005, pages 726 - 730, XP004733383

DOI:   http://dx.doi.org/10.1016/j.biocel.2004.11.005
    - WANG, Z.; N. BHATTACHARYA; M. WEAVER; K. PETERSEN; M. MEYER; L. GAPTER; N. S. MAGNUSON, "Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis", J VET SCI, (2001), vol. 2, pages 167 - 179, XP001246809
    - AMARAVADI, R.; C. B. THOMPSON, "The survival kinases Akt and Pim as potential pharmacological targets", J CLIN INVEST, (2005), vol. 115, pages 2618 - 2624
    - FOX, C. J.; P. S. HAMMERMAN; C. B. THOMPSON, "The Pim kinases control rapamycin- resistant T cell survival and activation", J EXP MED, (2005), vol. 201, doi:doi:10.1084/jem.20042020, pages 259 - 266, XP002437586

DOI:   http://dx.doi.org/10.1084/jem.20042020
    - AMSON, R.; F. SIGAUX; S. PRZEDBORSKI; G. FLANDRIN; D. GIVOL; A. TELERMAN, "The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias", PROC NATL ACAD SCI USA, (1989), vol. 86, pages 8857 - 8861
    - VALDMAN, A.; X. FANG; S. T. PANG; P. EKMAN; L. EGEVAD., "Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer", PROSTATE, (2004), vol. 60, pages 367 - 371
    - CIBULL, T. L.; T. D. JONES; L. LI; J. N. EBLE; L. ANN BALDRIDGE; S. R. MALOTT; Y. LUO; L. CHENG, "Overexpression of Pim-1 during progression of prostatic adenocarcinoma", J CLIN PATHOL, (2006), vol. 59, pages 285 - 288
    - NIEBOROWSKA-SKORSKA, M.; G. HOSER; P. KOSSEV; M. A. WASIK; T. SKORSKI., "Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-I in the BCR/ABL-mediated leukemogenesis", BLOOD, (2002), vol. 99, pages 4531 - 4539
    - TEMPLE, R.; E. ALLEN; J. FORDHAM; S. PHIPPS; H. C. SCHNEIDER; K. LINDAUER; I. HAYES; J. LOCKEY; K. POLLOCK; R. JUPP., "Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes", AM J RESPIR CELL MOL BIOL, (2001), vol. 25, pages 425 - 433, XP001037077
    - ANDINA, N.; S. DIDICHENKO; J. SCHMIDT-MENDE; C. A. DAHINDEN; H. U. SIMON, "Proviral integration site for Moloney murine leukemia virus 1, but not phosphatidylinositol-3 kinase, is essential in the antiapoptotic signaling cascade initiated by IL-5 in eosinophils", J ALLERGY CLIN IMMUNOL, (2009), vol. 123, doi:doi:10.1016/j.jaci.2008.12.004, pages 603 - 611, XP026033072

DOI:   http://dx.doi.org/10.1016/j.jaci.2008.12.004
    - STOUT, B. A.; M. E. BATES; L. Y. LIU; N. N. FARRINGTON; P. J. BERTICS, "IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophil", J IMMUNO, (2004), vol. 173, pages 6409 - 6417
    - BUSSE, W. W.; R. L. COFFMAN; E. W. GELFAND, A. B. KAY; L. J. ROSENWASSER, "Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products", AM J RESPIR CRIT CARE MED, (1995), vol. 152, pages 388 - 393
    - COHN, L.; R. J. HOMER; A. MARINOV; J. RANKIN; K. BOTTOMLY, "Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production", EXP MED, (1997), vol. 186, pages 1737 - 1747
    - HOGAN, S. P.; A. KOSKINEN; K. I. MATTHAEI; 1. G. YOUNG; P. S. FOSTER, "lnterleukin-5- producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice", AM J RESPIR CRIT CARE MED, (1998), vol. 15, no. 7, pages 210 - 218
    - AZZAWI, M.; B. BRADLEY; P. K. JEFFERY; A. J. FREW; A. J. WARDLAW; G. KNOWLES; B. ASSOUFI; J. V. COLLINS; S. DURHAM; A. B. KAY, "Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma", AM REV RESPIR DIS, (1990), vol. 142, pages 1407 - 1413
    - HAMELMANN, E.; A. OSHIBA; J. PALUH; K. BRADLEY; J. LOADER; T. A. POTTER; G. L. LARSEN; E. W. GELFAND, "Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization", J EXP MED, (1996), vol. 183, pages 1719 - 1729
    - ISOGAI, S.; R. TAHA; M. TAMAOKA; Y. YOSHIZAWA; Q. HAMID; J. G. MARTIN, "CD8+ alphabeta T cells can mediate late airway responses and airway eosinophilia in rats", J ALLERGY CLIN IMMUNOL, (2004), vol. 114, doi:doi:10.1016/j.jaci.2004.09.021, pages 1345 - 1352, XP004666375

DOI:   http://dx.doi.org/10.1016/j.jaci.2004.09.021
    - MIYAHARA, N.; K. TAKEDA; T. KODAMA; A. JOETHAM; C. TAUBE; J. W. PARK; S. MIYAHARA; A. BALHOM; A. DAKHAMA; E. W. GELFAND, "Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13", J IMMUNOL, (2004), vol. 172, doi:doi:10.4049/jimmunol.172.4.2549, pages 2549 - 2558, XP055267111

DOI:   http://dx.doi.org/10.4049/jimmunol.172.4.2549
    - MIYAHARA, N.; B. J. SWANSON; K. TAKEDA; C. TAUBE; S. MIYAHARA; T. KODAMA; A. DAKHAMA; V. L. OTT; E. W. GELFAND, "Effector CD8+ T cells mediate inflammation and airway hyper- responsiveness", NAT MED, (2004), vol. 10, pages 865 - 869
    - CROFT, M.; L. CARTER; S. L. SWAIN; R. W. DUTTON, "Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type I cytokine profiles", J EXP MED, (1994), vol. 180, pages 1715 - 1728
    - SEDER, R. A.; J. L. BOULAY; F. FINKELMAN; S. BARBIER; S. Z. BEN-SASSON; G. LE GROS; W. E. PAUL., "CD8+ T cells can be primed in vitro to produce IL-4", J IMMUNOL, (1992), vol. 148, pages 1652 - 1656
    - COYLE, A. J.; F. ERARD; C. BERTRAND; S. WALTI; H. PIRCHER; G. LE GROS, "Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia", J EXP MED, (1995), vol. 181, pages 1229 - 1233
    - TAKEDA, K.; N. MIYAHARA; T. KODAMA; C. TAUBE; A. BALHOM; A. DAKHAMA; K. KITAMURA; A. HIRANO; M. TANIMOTO; E. W. GELFAND, "S-carboxymethylcysteine normalises airway responsiveness in sensitised and challenged mice", EUR RESPIR J, (2005), vol. 26, pages 577 - 585
    - TAKEDA, K.; E. HAMELMANN; A. JOETHAM; L. D. SHULTZ; G. L. LARSEN; C. G. IRVIN; E. W. GELFAND, "Development ofeosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice", J EXP MED, (1997), vol. 186, pages 449 - 454
    - TOMKINSON, A.; G. CIESLEWICZ; C. DUEZ; K. A. LARSON; J. J. LEE; E. W. GELFAND, "Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin- sensitized mice", AM J RESPIR CRIT CARE MED, (2001), vol. 163, pages 721 - 730
    - OSHIBA, A.; E. HAMELMANN; K. TAKEDA; K. L. BRADLEY; J. E. LOADER; G. L. LARSEN; E. W. GELFAND, "Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG I in mice", CLIN INVEST, (1996), vol. 97, pages 1398 - 1408
    - CHENG, J. Q.; A. K. GODWIN; A. BELLACOSA; T. TAGUCHI; T. F. FRANKE; T. C. HAMILTON; P. N. TSICHLIS; J. R. TESTA, "AKT2, a putative oncogene encoding a member of a subfamily of protein- serine/threonine kinases, is amplified in human ovarian carcinomas", PROC NATL ACAD SCI USA, (1992), vol. 89, doi:doi:10.1073/pnas.89.19.9267, pages 9267 - 9271, XP002925403

DOI:   http://dx.doi.org/10.1073/pnas.89.19.9267
    - BELLACOSA, A.; D. DE FEO; A. K. GODWIN; D. W. BELL; J. Q. CHENG; D. A. ALTOMARE; M. WAN; L. DUBEAU; G. SCAMBIA; V. MASCIULLO, "Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas", INT J CANCER, (1995), vol. 64, pages 280 - 285
    - STAHL, J. M.; A. SHARMA; M. CHEUNG; M. ZIMMERMAN; J. Q. CHENG; M. W. BOSENBERG; M. KESTER; L. SANDIRASEGARANE; G. P. ROBERTSON, "Deregulated Akt3 activity promotes development of malignant melanoma", CANCER RES, (2004), vol. 64, doi:doi:10.1158/0008-5472.CAN-04-1399, pages 7002 - 7010, XP002402151

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-04-1399
    - MASURE, S.; B. HAEFNER; J. J. WESSELINK; E. HOEFNAGEL; E. MORTIER; P. VERHASSELT; A. TUYTELAARS; R. GORDON; A. RICHARDSON, "Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3", EUR J BIOCHEM, (1999), vol. 265, doi:doi:10.1046/j.1432-1327.1999.00774.x, pages 353 - 360, XP002939959

DOI:   http://dx.doi.org/10.1046/j.1432-1327.1999.00774.x
    - YANG, L.; H. C. DAN; M. SUN; Q. LIU; X. M. SUN; R. I. FELDMAN; A. D. HAMILTON; M. POLOKOFF; S. V. NICOSIA; M. HERLYN, "Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt", CANCER RES, (2004), vol. 64, doi:doi:10.1158/0008-5472.CAN-04-0343, pages 4394 - 4399, XP009075866

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-04-0343
    - KONDAPAKA, S. B.; S. S. SINGH; G. P. DASMAHAPATRA; E. A. SAUSVILLE; K. K. ROY, "Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation", MOL CANCER THER, (2003), vol. 2, pages 1093 - 1103
    - VAN LOHUIZEN, M.; S. VERBEEK; P. KRIMPENFORT; J. DOMEN; C. SARIS; T. RADASZKIEWICZ; A. BERNS, "Predisposition to lymphomagenesis in pim- transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors", CELL, (1989), vol. 56, doi:doi:10.1016/0092-8674(89)90589-8, pages 673 - 682, XP023884103

DOI:   http://dx.doi.org/10.1016/0092-8674(89)90589-8
    - MIKKERS, H.; M. NAWIJN; J. ALLEN; C. BROUWERS; E. VERHOEVEN; J. JONKERS; A. BERNS, "Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors", MOL CELL BIOL, (2004), vol. 24, pages 6104 - 6115
    - KATAKAMI, N.; H. KANETO; H. HAO; Y. UMAYAHARA; Y. FUJITANI; K. SAKAMOTO; S. GOROGAWA; T. YASUDA; D. KAWAMORI; Y. KAJIMOTO, "Role ofpim-1 in smooth muscle cell proliferation", J BIOL CHEM, (2004), vol. 279, pages 54742 - 54749
    - CHEN, L. S.; S. REDKAR; D. BEARSS; W. G. WIERDA; V. GANDHI, "Pim kinase inhibitor, SGI- 1776, induces apoptosis in chronic lymphocytic leukemia cells", BLOOD, (2009), vol. 114, doi:doi:10.1182/blood-, pages 4150 - 4157, XP055395124

DOI:   http://dx.doi.org/10.1182/blood-2009-03-212852
    - HU, X. F.; J. LI; S. VANDERVALK; Z. WANG; N. S. MAGNUSON; P. X. XING, "PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis", J CLIN INVEST, (2009), vol. 119, pages 362 - 375
    - BORGONOVO, B.; G. CASORATI; E. FRITTOLI; D. GAFFI; E. CRIMI; S. E. BURASTERO, "Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma", J ALLERGY CLIN IMMUNOL, (1997), vol. 100, doi:doi:10.1016/S0091-6749(97)70172-6, pages 669 - 678, XP005138207

DOI:   http://dx.doi.org/10.1016/S0091-6749(97)70172-6
    - YAN, B.; M. ZEMSKOVA; S. HOLDER; V. CHIN; A. KRAFT; P. J. KOSKINEN; M. LILLY, "The PIM- 2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death", J BIOL CHEM, (2003), vol. 278, pages 45358 - 45367
    - CHEN, X. P.; J. A. LOSMAN; S. COWAN; E. DONAHUE; S. FAY; B. Q. VUONG; M. C. NAWIJN; D. CAPECE; V. L. COHAN; P. ROTHMAN, "Pim serine/threonine kinases regulate the stability of Socs- protein", PROC NATL ACAD SCI USA, (2002), vol. 99, doi:doi:10.1073/pnas.042035699, pages 2175 - 2180, XP002951644

DOI:   http://dx.doi.org/10.1073/pnas.042035699
    - MAITA, H.; Y. HARADA; D. NAGAKUBO; H. KITAURA; M. IKEDA; K. TAMAI; K. TAKAHASHI; H. ARIGA; S. M. IGUCHI-ARIGA, "PAP-1, a novel target protein of phosphorylation by pim-1 kinase", EUR J BIOCHEM, (2000), vol. 267, doi:doi:10.1046/j.1432-1327.2000.01585.x, pages 5168 - 5178, XP002986526

DOI:   http://dx.doi.org/10.1046/j.1432-1327.2000.01585.x
    - KOIKE, N.; H. MAITA; T. TAIRA; H. ARIGA; S. M. IGUCHI-ARIGA, "Identification of heterochromatin protein 1 (HP I) as a phosphorylation target by Pim-l kinase and the effect of phosphorylation on the transcriptional repression function of HPI(I", FEBS LETT, (2000), vol. 467, doi:doi:10.1016/S0014-5793(00)01105-4, pages 17 - 21, XP004260914

DOI:   http://dx.doi.org/10.1016/S0014-5793(00)01105-4
    - WANG, Z.; N. BHATTACHARYA; M. K. MEYER; H. SEIMIYA; T. TSURUO; J. A. TONANI; N. S. MAGNUSON, "Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells", ARCH BIOCHEM BIOPHYS, (2001), vol. 390, pages 9 - 18
    - RAINIO, E. M.; J. SANDHOLM; P. J. KOSKINEN, "Cutting edge: Transcriptional activity of NFATcl is enhanced by the Pim-1 kinase", J IMMUNOL, (2002), vol. 168, pages 1524 - 1527
    - PATRA, A. K.; T. DREWES; S. ENGELMANN; S. CHUVPILO; H. KISHI; T. HUNIG; E. SERFLING; U. H. BOMMHARDT, "PKB rescues calcineurin/NFAT-induced arrest of Rag expression and pre-T cell differentiation", J IMMUNOL, (2006), vol. 177, pages 4567 - 4576
    - BUSSE, W. W.; R. F. LEMANSKE, JR., "Asthma", N ENGL J MED, (2001), vol. 344, pages 350 - 362
    - ROSENBERG, H. F.; S. PHIPPS; P. S. FOSTER, "Eosinophil trafficking in allergy and asthma", J ALLERGY CLIN IMMUNOL, (2007), vol. 119, doi:doi:10.1016/j.jaci.2007.03.048, pages 1303 - 1310, XP022096880

DOI:   http://dx.doi.org/10.1016/j.jaci.2007.03.048
    - LARCHE, M.; D. S. ROBINSON; A. B. KAY, "The role of T lymphocytes in the pathogenesis of asthma", JALLERGY CLIN IMMUNOL, (2003), vol. 111, doi:doi:10.1067/mai.2003.169, pages 450 - 463, XP002971058

DOI:   http://dx.doi.org/10.1067/mai.2003.169
    - MULLARKEY, M. F.; B. A. BLUMENSTEIN; W. P. ANDRADE; G. A. BAILEY; 1. OLASON; C. E. WETZEL., "Methotrexate in the treatment of crticosteroid-dependent asthma. A double-blind crossover study", N ENGL J MED, (1988), vol. 318, pages 603 - 607
    - ALEXANDER, A. G.; N. C. BARNES; A. B. KAY, "Trial of cyclosporin in corticosteroid- dependent chronic severe asthma", LANCET, (1992), vol. 339, pages 324 - 328
    - KWEON MN; YAMAMOTO M; KAJIKI M; TAKAHASHI I; KIYONO H, "Systemically derived large intestinal CD4 (+) Th2 cells play a central role in STAT6-mediated allergic diarrhea", J CLIN INVEST, (2000), vol. 106, pages 199 - 206
    - WANG M; TAKEDA K; SHIRAISHI Y; OKAMOTO M; DAKHAMA A; JOETHAM A; GELFAND EW, "Peanut- Induced Intestinal Allergy is Mediated Through a Mast Cell-IgE-Fc?RI-IL-13 Pathway", J. ALLERGY CLIN IMMUNOL, (2010), vol. 126, no. 2, pages 306 - 316
    - KNIGHT AK; BLAZQUEZ AB; ZHANG S; MAYER L; SAMPSON HA; BERIN MC, "CD4 T cells activated in the mesenteric lymph node mediate gastrointestinal food allergy in mice", AM J PHYSIOL GASTROINTEST LIVER PHYSIOL., (2007), vol. 293, no. 6, pages G 1234 - 43
    - KWEON MN; YAMAMOTO M; KAJIKI M; TAKAHASHI I; KIYONO H, "Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea", J CLIN INVEST., (2000), vol. 106, no. 2, pages 199 - 206
    - EIGENMANN PA., "T lymphocytes in food allergy: overview of an intricate network of circulating and organ-resident cells", PEDIATR ALLERGY IMMUNOL, (2002), vol. 13, pages 162 - 71
    - EIGENMANN PA; HUANG SK; HO DG; SAMPSON HA, "Human T cell clones and cell lines specific to ovomucoid recognize different domains and consistently express IL-5", ADV EXP MED BIOL, (1996), vol. 409, page 217
    - BLUMCHEN K; ULBRICHT H; STADEN U; DOBBERSTEIN K; BESCHORNER J; DE OLIVEIRA LC; SHREFFLER WG; SAMPSON HA; NIGGEMANN B; WAHN U, "Oral peanut immunotherapy in children with peanut anaphylaxis", J ALLERGY CLIN IMMUNOL., (2010), vol. 126, no. 1, doi:doi:10.1016/J.JACI.2010.04.030, pages 83 - 91, XP002675004

DOI:   http://dx.doi.org/10.1016/J.JACI.2010.04.030
    - KOLLS JK; LINDEN A., "Interleukin-17 family members and inflammation", IMMUNITY, (2004), vol. 21, doi:doi:10.1016/j.immuni.2004.08.018, pages 467 - 476, XP001205649

DOI:   http://dx.doi.org/10.1016/j.immuni.2004.08.018
    - IVANOV II; MCKENZIE BS; ZHOU L; TADOKORO CE; LEPELLEY A; LAFAILLE JJ; CUA DJ; LITTMAN DR, "The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL- 17+ T helper cells", CELL., (2006), vol. 126, no. 6, doi:doi:10.1016/j.cell.2006.07.035, pages 1121 - 33, XP008091324

DOI:   http://dx.doi.org/10.1016/j.cell.2006.07.035
    - WANG Z; BHATTACHARYA N; WEAVER M; PETERSEN K; MEYER M; GAPTER L; MAGNUSON NS., "Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis", J VET SCI., (2001), vol. 2, no. 3, pages 167 - 179, XP001246809
    - AHO TL; SANDHOLM J; PELTOLA KJ; ITO Y; KOSKINEN PJ, "Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity", BMC CELL BIOL., (2006), vol. 7, pages 21 - 29
    - RAINIO EM; SANDHOLM J; KOSKINEN PJ, "Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase", J IMMUNOL., (2002), vol. 168, no. 4, pages 1524 - 7
    - WINGETT D; LONG A; KELLEHER D; MAGNUSON NS, "pim-1 proto-oncogene expression in anti-CD3- mediated T cell activation is associated with protein kinase C activation and is independent of Raf- 1.", J IMMUNOL., (1996), vol. 156, no. 2, pages 549 - 57
    - TESMER LA; LUNDY SK; SARKAR S; FOX DA, "Th 17 cells in human disease", IMMUNOL REV., (2008), vol. 223, doi:doi:10.1111/j.1600-065X.2008.00628.x, pages 87 - 113, XP055049269

DOI:   http://dx.doi.org/10.1111/j.1600-065X.2008.00628.x
    - BRENNER O; LEVANON D; NEGREANU V; GOLUBKOV 0; FAINARU O; WOOLF E; GRONER Y, "Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia", PROC NATL ACAD SCI USA., (2004), vol. 101, no. 45, doi:doi:10.1073/PNAS.0407180101, pages 16016 - 21, XP008125973

DOI:   http://dx.doi.org/10.1073/PNAS.0407180101
    - FAINARU O; WOOLF E; LOTEM J; YARMUS M; BRENNER O; GOLDENBERG D; NEGREANU V; BERNSTEIN Y; LEVANON D; JUNG S, "Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation", EMBO J., (2004), vol. 23, no. 4, doi:doi:10.1038/sj.emboj.7600085, pages 969 - 79, XP002991563

DOI:   http://dx.doi.org/10.1038/sj.emboj.7600085
    - KOMINE O; HAYASHI K; NATSUME W; WATANABE T; SEKI Y; SEKI N; YAGI R; SUKZUKI W; TAMAUCHI H; HOZUMI K, "The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression", J EXP MED., (2003), vol. 198, no. 1, pages 51 - 61
    - NAWIJN MC; ALENDAR A; BERNS A, "For better or for worse: the role of Pim oncogenes in tumorigenesis", NAT REV CANCER, (2011), vol. 11, pages 23 - 34
    - KICIC A; HALLSTRAND TS; SUTANTO EN; STEVENS PT; KOBOR MS; TAPLIN C; PARE PD; BEYER RP; STICK SM; KNIGHT DA, "Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium", AM J RESPIR CRIT CARE MED., vol. 20 10, no. 181, pages 889 - 98
    - LACK G; RENZ H; SALOGA J; BRADLEY KL; LOADER JE; LEUNG DYM; LARSEN GL; GELFAND EW, "Nebulized but not parenteral IFN-? decreases IgE production and normalizes airway function in a murine model of allergen sensitization", J IMMUNOL, (1994), vol. 152, pages 25446 - 25454
    - FLAISHON L; TOPILAKI I; SHOSEYOV D; HERSHKOVIZ R; FIREMAN E; LEVO Y; MARMOR S; SHACHAR I., "Anti- inflammatory properties of low levels of IFN-?", J IMMUNOL, (2002), vol. 168, pages 3707 - 3711
    - YOSHIDA M; LEIGH R; MATSUMOTO K; WATTIE J; ELLIS R; O'BYME PM; INMAN MD, "Effect of interferon-? on allergic airway responses in interferon-gamma-deficient mice", AMER J RESP CRIT CARE MED, (2002), vol. 166, pages 451 - 456
    - HESSEL EM; VAN OOSTERHOUT AJ; VAN ARK I; VAN ESCH B; HOFMAN G; VAN LOVEREN H; SAVELKOUL HF; NIJKAMP FP, "Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration", AMER J RESP CELL MOLEC BIOL, (1997), vol. 16, pages 325 - 334
    - TEN HACKEN NHT; OOSTERHOFFY, KAUFFMAN HF; GUEVARRA L; SATOH T; TOLLERUD DJ; POSTMA DS., "Elevated serum interferon-y in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation", EUR RESP J, (1998), vol. 11, pages 312 - 316
    - HEATON T; ROWE J; TURNER S; AALBERSE RC; DE KLERK N; SURIYAARACHCHI D; SERRALHA M; HOLT BJ; HOLLAMS E; YERKOVICH S, "An immunoepidemiological approach to asthma: Identification of in-vitro T cell response patterns associated with different wheezing phenotypes in children", LANCET, (2005), vol. 365, doi:doi:10.1016/S0140-6736(05)17704-6, pages 142 - 149, XP025276340

DOI:   http://dx.doi.org/10.1016/S0140-6736(05)17704-6
    - LOPEZ AF; SANDERSON CJ; GAMBLE JR; CAMPBELL HD; YOUNG IG; VADAS MA, "Recombinant human interleukin 5 is a selective activator of human eosinophil function", J EXP MED, (1988), vol. 167, pages 219 - 224
    - LAOUKILI J; PERRET E; WILLEMS T; MINTY A; PARTHOENS E; HOUCINE O; COSTE A; JORISSEN M; MARANO F; CAPUT D, "IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells", J CLIN INVEST, (2001), vol. 108, pages 1817 - 1824
    - COHN L; TEPPER JS; BOTTOMLY K., "IL-4-independent induction of airway hyperresponsiveness by Th2, but not Thl, cells", J IMMUNOL, (1998), vol. 161, pages 3813 - 3816
    - PERRIER C; THIERRY AC; MERCENIER A; CORTHESY B, "Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice", CLIN EXP ALLERGY, (2010), vol. 40, pages 153 - 162, XP009191561
    - TANIUCHI I; OSATO M; EGAWA T; SUNSHINE MJ; BAE SC; KOMORI T; ITO Y; LITTMAN DR, "Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development", CELL, (2002), vol. 111, pages 621 - 633
    - CRUZ-GUILLOTY F; PIPKIN ME; DJURETIC IM; LEVANON D; LOTEM J; LICHTENHELD MG; GRONER Y; RAO A, "Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs", J EXP MED, (2009), vol. 206, pages 51 - 59
    - DJURETIC IM; LEVANON D; NEGREANU V; GRONER Y; RAO A; ANSEL KM, "Transcription factors T-bet and Runx3 cooperate to activate IFN? and silence IL4 in T helper type I cells", NAT IMMUNOL, (2007), vol. 8, pages 145 - 153
    - KOHU K; OHMORI H; WONG WF; ONDA D; WAKOH T; KON S; YAMASHITA M; NAKAYAMA T; KUBO M; SATAKE M, "The Runx3 transcription factor augments Th 1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3", J IMMUNOL, (2009), vol. 183, pages 7817 - 7824
    - LEE SH; JEONG HM; CHOI JM; CHO YC; KIM TS; LEE KY; KANG BY, "Runx3 inhibits IL-4 production in T cells via physical interaction with NFAT", BIOCHEM BIOPHYS RES COMMUN, (2009), vol. 381, doi:doi:10.1016/j.bbrc.2009.02.026, pages 214 - 217, XP025974856

DOI:   http://dx.doi.org/10.1016/j.bbrc.2009.02.026
    - AUJLA M., "Targeted therapies: Pim kinase inhibition and chemoresistance", NAT REV CLIN ONCOL, (2010), vol. 7, page 3
    - BRAULT L; GASSER C; BRACHER F; HUBER K; KNAPP S; SCHWALLER L, "PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers", HAEMATOLOGICA, (2010), vol. 95, pages 1004 - 1015
    - AHO TL; LUND RJ; YLIKOSKI EK; MATIKAINEN S; LAHESMAA R; KOSKINEN PJ, "Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation", IMMUNOLOGY, (2005), vol. 116, doi:doi:10.1111/j.1365-2567.2005.02201.x, pages 82 - 88, XP055144292

DOI:   http://dx.doi.org/10.1111/j.1365-2567.2005.02201.x
    - DAUTRY F; WEIL D; YU J; DAUTRY-VARSAT A, "Regulation ofpim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines", J BIOL CHEM, (1988), vol. 263, pages 17615 - 17620
    - LILLY M; LE T; HOLLAND P; HENDRICKSON SL, "Sustained expression of the pim-I kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related", ONCOGENE, (1992), vol. 7, pages 727 - 732
    - MATIKAINEN S; SARENEVA T; RONNI T; LEHTONEN A; KOSKINEN PJ; JULKUNEN I, "Interferon-a activates multiple STAT proteins and up-regulates proliferation-associated IL-2R?, c-myc, and pim- I genes in human T cells", BLOOD, (1999), vol. 93, pages 1980 - 1991
    - JACKSON LJ; WRIGHT D; GROSS S; ROBINSON J; MARMSATER FP; ALLEN S; MUNSON M; CARTER LL, "Inhibition of T cell function in vitro and in vivo using small molecule antagonists of PIM kinases", J IMMUNOL, (2009), vol. 182, page 35.33
    - WALTER DM; MCINTIRE JJ; BERRY G; MCKENZIE AN; DONALDSON DD; DEKRUYFF RH; UMETSU DT, "Critical role for IL-13 in the development of allergen induced airway hyperreactivity", J IMMUNOL, (2001), vol. 167, pages 4668 - 4675, XP002542096
    - MIYAHARA S; MIYAHARA N; MATSUBARA S; TAKEDA K; KOYA T; GELFAND EW., "IL-13 is essential to the late-phase response in allergic rhinitis", J ALLERGY CLIN IMMUNOL, (2006), vol. 118, doi:doi:10.1016/j.jaci.2006.06.014, pages 1110 - 1116, XP005844186

DOI:   http://dx.doi.org/10.1016/j.jaci.2006.06.014
    - DONALDSON DD; WHITTERS MJ; FITZ LJ; NEBEN TY; FINNERTY H; HENDERSON SL; O'HARA JR RM; BEIER DR; TURNER KJ; WOOD CR, "The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1", J IMMUNOL, (1998), vol. 161, pages 2317 - 2324, XP002195293
    - TAUBE C; MIYAHARA N; OTT V; SWANSON B; TAKEDA K; LOADER J; SHULTZ LD; TAGER AM; LUSTER AD; DAKHAMA A, "The leukotriene B4 receptor (BLTI) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness", J IMMUNOL, (2006), vol. 176, pages 3157 - 3164
    - WANG YH; VOO KS; LIU B; CHEN CY; UYGUNGIL B; SPOEDE W; BERNSTEIN JA; HUSTON DP; LIU YJ., "A novel subset of CD4 (+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma", J EXP MED, (2010), vol. 207, pages 2479 - 2491
    - SZABO SJ; KIM ST; COSTA GL; ZHANG X; FATHMAN CG; GLIMCHER LH, "A novel transcription factor, bet, directs Thl lineage commitment", CELL, (2000), vol. 100, pages 655 - 669
    - ZHANG DH; COHN L; RAY P; BOTTOMLY K; RAY A, "Transcription factor GATA-3 is differentially expressed in murine Th and Th2 cells and controls Th2-specitic expression of the interleukin-5 gene", J BIOL CHEM, (1997), vol. 272, pages 21597 - 21603
    - ZHENG W; FLAVELL RA, "The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells", CELL, (1997), vol. 89, pages 587 - 596
    - ZHOU L; LOPES JE; CHONG MM; IVANOV II; MIN R; VICTORA GD; SHEN Y; DU J; RUBTSOV YP; RUDENSKY AY, "TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function", NATURE, (2008), vol. 453, doi:doi:10.1038/nature06878, pages 236 - 240, XP055190401

DOI:   http://dx.doi.org/10.1038/nature06878
    - OKAMOTO K; IWAI Y; OH-HORA M; YAMAMOTO M; MORIO T; AOKI K; OHYA K; JETTEN AM; AKIRA S; MUTA T, "IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors", NATURE, (2010), vol. 464, doi:doi:10.1038/nature08922, pages 1381 - 1385, XP055126967

DOI:   http://dx.doi.org/10.1038/nature08922
    - ICHIYAMA K; YOSHIDA H; WAKABAYASHI Y; CHINEN T; SAEKI K; NAKAYA M; TAKAESU G; HORI S; YOSHIMURA A; KOBAYASHI T, "Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat", J BIOL CHEM, (2008), vol. 283, pages 17003 - 17008
    - ZHOU L; IVANOV II; SPOLSKI R; MIN R; SHENDEROV K; EGAWA T; LEVY DE; LEONARD WJ; LITTMAN DR, "IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways", NAT IMMUNOL, (2007), vol. 8, doi:doi:10.1038/ni1488, pages 967 - 974, XP055022809

DOI:   http://dx.doi.org/10.1038/ni1488
    - LI XM; SEREBRISKY D; LEE SY; HUANG CK; BARDINA L; SCHOFIELD BH; STANLEY JS; BURKS AW; BANNON GA; SAMPSON HA, "A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses", J ALLERGY CLIN IMMUNOL, (2000), vol. 106, doi:doi:10.1067/mai.2000.107395, pages 150 - 158, XP055138450

DOI:   http://dx.doi.org/10.1067/mai.2000.107395
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.